US 11236139
Combination immunotherapy
granted A61KA61K2039/5256A61K2039/54
Quick answer
US patent 11236139 (Combination immunotherapy) held by The United States Government represented by the Department of Veterans Affairs expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States Government represented by the Department of Veterans Affairs
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/5256, A61K2039/54, A61K2039/545, A61K2239/31